Literature DB >> 26629640

Defining the Effect of the 16p11.2 Duplication on Cognition, Behavior, and Medical Comorbidities.

Debra D'Angelo1, Sébastien Lebon2, Qixuan Chen1, Sandra Martin-Brevet3, LeeAnne Green Snyder4, Loyse Hippolyte3, Ellen Hanson5, Anne M Maillard3, W Andrew Faucett6, Aurélien Macé7, Aurélie Pain3, Raphael Bernier8, Samuel J R A Chawner9, Albert David10, Joris Andrieux11, Elizabeth Aylward12, Genevieve Baujat13, Ines Caldeira3, Philippe Conus14, Carrina Ferrari14, Francesca Forzano15, Marion Gérard16, Robin P Goin-Kochel17, Ellen Grant18, Jill V Hunter19, Bertrand Isidor10, Aurélia Jacquette20, Aia E Jønch3, Boris Keren21, Didier Lacombe22, Cédric Le Caignec10, Christa Lese Martin23, Katrin Männik24, Andres Metspalu25, Cyril Mignot18, Pratik Mukherjee26, Michael J Owen9, Marzia Passeggeri3, Caroline Rooryck-Thambo27, Jill A Rosenfeld28, Sarah J Spence29, Kyle J Steinman30, Jennifer Tjernagel4, Mieke Van Haelst31, Yiping Shen32, Bogdan Draganski33, Elliott H Sherr34, David H Ledbetter23, Marianne B M van den Bree9, Jacques S Beckmann7, John E Spiro35, Alexandre Reymond36, Sébastien Jacquemont37, Wendy K Chung38.   

Abstract

IMPORTANCE: The 16p11.2 BP4-BP5 duplication is the copy number variant most frequently associated with autism spectrum disorder (ASD), schizophrenia, and comorbidities such as decreased body mass index (BMI).
OBJECTIVES: To characterize the effects of the 16p11.2 duplication on cognitive, behavioral, medical, and anthropometric traits and to understand the specificity of these effects by systematically comparing results in duplication carriers and reciprocal deletion carriers, who are also at risk for ASD. DESIGN, SETTING, AND PARTICIPANTS: This international cohort study of 1006 study participants compared 270 duplication carriers with their 102 intrafamilial control individuals, 390 reciprocal deletion carriers, and 244 deletion controls from European and North American cohorts. Data were collected from August 1, 2010, to May 31, 2015 and analyzed from January 1 to August 14, 2015. Linear mixed models were used to estimate the effect of the duplication and deletion on clinical traits by comparison with noncarrier relatives. MAIN OUTCOMES AND MEASURES: Findings on the Full-Scale IQ (FSIQ), Nonverbal IQ, and Verbal IQ; the presence of ASD or other DSM-IV diagnoses; BMI; head circumference; and medical data.
RESULTS: Among the 1006 study participants, the duplication was associated with a mean FSIQ score that was lower by 26.3 points between proband carriers and noncarrier relatives and a lower mean FSIQ score (16.2-11.4 points) in nonproband carriers. The mean overall effect of the deletion was similar (-22.1 points; P < .001). However, broad variation in FSIQ was found, with a 19.4- and 2.0-fold increase in the proportion of FSIQ scores that were very low (≤40) and higher than the mean (>100) compared with the deletion group (P < .001). Parental FSIQ predicted part of this variation (approximately 36.0% in hereditary probands). Although the frequency of ASD was similar in deletion and duplication proband carriers (16.0% and 20.0%, respectively), the FSIQ was significantly lower (by 26.3 points) in the duplication probands with ASD. There also were lower head circumference and BMI measurements among duplication carriers, which is consistent with the findings of previous studies. CONCLUSIONS AND RELEVANCE: The mean effect of the duplication on cognition is similar to that of the reciprocal deletion, but the variance in the duplication is significantly higher, with severe and mild subgroups not observed with the deletion. These results suggest that additional genetic and familial factors contribute to this variability. Additional studies will be necessary to characterize the predictors of cognitive deficits.

Entities:  

Mesh:

Year:  2016        PMID: 26629640      PMCID: PMC5894477          DOI: 10.1001/jamapsychiatry.2015.2123

Source DB:  PubMed          Journal:  JAMA Psychiatry        ISSN: 2168-622X            Impact factor:   21.596


  26 in total

1.  Structural variation of chromosomes in autism spectrum disorder.

Authors:  Christian R Marshall; Abdul Noor; John B Vincent; Anath C Lionel; Lars Feuk; Jennifer Skaug; Mary Shago; Rainald Moessner; Dalila Pinto; Yan Ren; Bhooma Thiruvahindrapduram; Andreas Fiebig; Stefan Schreiber; Jan Friedman; Cees E J Ketelaars; Yvonne J Vos; Can Ficicioglu; Susan Kirkpatrick; Rob Nicolson; Leon Sloman; Anne Summers; Clare A Gibbons; Ahmad Teebi; David Chitayat; Rosanna Weksberg; Ann Thompson; Cathy Vardy; Vicki Crosbie; Sandra Luscombe; Rebecca Baatjes; Lonnie Zwaigenbaum; Wendy Roberts; Bridget Fernandez; Peter Szatmari; Stephen W Scherer
Journal:  Am J Hum Genet       Date:  2008-01-17       Impact factor: 11.025

2.  The cognitive and behavioral phenotype of the 16p11.2 deletion in a clinically ascertained population.

Authors:  Ellen Hanson; Raphael Bernier; Ken Porche; Frank I Jackson; Robin P Goin-Kochel; LeeAnne Green Snyder; Anne V Snow; Arianne Stevens Wallace; Katherine L Campe; Yuan Zhang; Qixuan Chen; Debra D'Angelo; Andres Moreno-De-Luca; Patrick T Orr; K B Boomer; David W Evans; Stephen Kanne; Leandra Berry; Fiona K Miller; Jennifer Olson; Elliot Sherr; Christa L Martin; David H Ledbetter; John E Spiro; Wendy K Chung
Journal:  Biol Psychiatry       Date:  2014-06-16       Impact factor: 13.382

3.  Opposing brain differences in 16p11.2 deletion and duplication carriers.

Authors:  Abid Y Qureshi; Sophia Mueller; Abraham Z Snyder; Pratik Mukherjee; Jeffrey I Berman; Timothy P L Roberts; Srikantan S Nagarajan; John E Spiro; Wendy K Chung; Elliott H Sherr; Randy L Buckner
Journal:  J Neurosci       Date:  2014-08-20       Impact factor: 6.167

4.  Identification of de novo copy number variants associated with human disorders of sexual development.

Authors:  Mounia Tannour-Louet; Shuo Han; Sean T Corbett; Jean-Francois Louet; Svetlana Yatsenko; Lindsay Meyers; Chad A Shaw; Sung-Hae L Kang; Sau Wai Cheung; Dolores J Lamb
Journal:  PLoS One       Date:  2010-10-26       Impact factor: 3.240

5.  Infantile spasms are associated with abnormal copy number variations.

Authors:  Vijay N Tiwari; Senthil K Sundaram; Harry T Chugani; A H M M Huq
Journal:  J Child Neurol       Date:  2012-08-21       Impact factor: 1.987

6.  Phenotypic spectrum associated with de novo and inherited deletions and duplications at 16p11.2 in individuals ascertained for diagnosis of autism spectrum disorder.

Authors:  Bridget A Fernandez; Wendy Roberts; Brian Chung; Rosanna Weksberg; Stephen Meyn; Peter Szatmari; Ann M Joseph-George; Sara Mackay; Kathy Whitten; Barbara Noble; Cathy Vardy; Victoria Crosbie; Sandra Luscombe; Eva Tucker; Lesley Turner; Christian R Marshall; Stephen W Scherer
Journal:  J Med Genet       Date:  2009-09-15       Impact factor: 6.318

7.  Recurrent reciprocal 16p11.2 rearrangements associated with global developmental delay, behavioural problems, dysmorphism, epilepsy, and abnormal head size.

Authors:  Marwan Shinawi; Pengfei Liu; Sung-Hae L Kang; Joseph Shen; John W Belmont; Daryl A Scott; Frank J Probst; William J Craigen; Brett H Graham; Amber Pursley; Gary Clark; Jennifer Lee; Monica Proud; Amber Stocco; Diana L Rodriguez; Beth A Kozel; Steven Sparagana; Elizabeth R Roeder; Susan G McGrew; Thaddeus W Kurczynski; Leslie J Allison; Stephen Amato; Sarah Savage; Ankita Patel; Pawel Stankiewicz; Arthur L Beaudet; Sau Wai Cheung; James R Lupski
Journal:  J Med Genet       Date:  2009-11-12       Impact factor: 6.318

8.  Mirror extreme BMI phenotypes associated with gene dosage at the chromosome 16p11.2 locus.

Authors:  Sébastien Jacquemont; Alexandre Reymond; Flore Zufferey; Louise Harewood; Robin G Walters; Zoltán Kutalik; Danielle Martinet; Yiping Shen; Armand Valsesia; Noam D Beckmann; Gudmar Thorleifsson; Marco Belfiore; Sonia Bouquillon; Dominique Campion; Nicole de Leeuw; Bert B A de Vries; Tõnu Esko; Bridget A Fernandez; Fernando Fernández-Aranda; José Manuel Fernández-Real; Mònica Gratacòs; Audrey Guilmatre; Juliane Hoyer; Marjo-Riitta Jarvelin; R Frank Kooy; Ants Kurg; Cédric Le Caignec; Katrin Männik; Orah S Platt; Damien Sanlaville; Mieke M Van Haelst; Sergi Villatoro Gomez; Faida Walha; Bai-Lin Wu; Yongguo Yu; Azzedine Aboura; Marie-Claude Addor; Yves Alembik; Stylianos E Antonarakis; Benoît Arveiler; Magalie Barth; Nathalie Bednarek; Frédérique Béna; Sven Bergmann; Mylène Beri; Laura Bernardini; Bettina Blaumeiser; Dominique Bonneau; Armand Bottani; Odile Boute; Han G Brunner; Dorothée Cailley; Patrick Callier; Jean Chiesa; Jacqueline Chrast; Lachlan Coin; Charles Coutton; Jean-Marie Cuisset; Jean-Christophe Cuvellier; Albert David; Bénédicte de Freminville; Bruno Delobel; Marie-Ange Delrue; Bénédicte Demeer; Dominique Descamps; Gérard Didelot; Klaus Dieterich; Vittoria Disciglio; Martine Doco-Fenzy; Séverine Drunat; Bénédicte Duban-Bedu; Christèle Dubourg; Julia S El-Sayed Moustafa; Paul Elliott; Brigitte H W Faas; Laurence Faivre; Anne Faudet; Florence Fellmann; Alessandra Ferrarini; Richard Fisher; Elisabeth Flori; Lukas Forer; Dominique Gaillard; Marion Gerard; Christian Gieger; Stefania Gimelli; Giorgio Gimelli; Hans J Grabe; Agnès Guichet; Olivier Guillin; Anna-Liisa Hartikainen; Délphine Heron; Loyse Hippolyte; Muriel Holder; Georg Homuth; Bertrand Isidor; Sylvie Jaillard; Zdenek Jaros; Susana Jiménez-Murcia; Géraldine Joly Helas; Philippe Jonveaux; Satu Kaksonen; Boris Keren; Anita Kloss-Brandstätter; Nine V A M Knoers; David A Koolen; Peter M Kroisel; Florian Kronenberg; Audrey Labalme; Emilie Landais; Elisabetta Lapi; Valérie Layet; Solenn Legallic; Bruno Leheup; Barbara Leube; Suzanne Lewis; Josette Lucas; Kay D MacDermot; Pall Magnusson; Christian Marshall; Michèle Mathieu-Dramard; Mark I McCarthy; Thomas Meitinger; Maria Antonietta Mencarelli; Giuseppe Merla; Alexandre Moerman; Vincent Mooser; Fanny Morice-Picard; Mafalda Mucciolo; Matthias Nauck; Ndeye Coumba Ndiaye; Ann Nordgren; Laurent Pasquier; Florence Petit; Rolph Pfundt; Ghislaine Plessis; Evica Rajcan-Separovic; Gian Paolo Ramelli; Anita Rauch; Roberto Ravazzolo; Andre Reis; Alessandra Renieri; Cristobal Richart; Janina S Ried; Claudine Rieubland; Wendy Roberts; Katharina M Roetzer; Caroline Rooryck; Massimiliano Rossi; Evald Saemundsen; Véronique Satre; Claudia Schurmann; Engilbert Sigurdsson; Dimitri J Stavropoulos; Hreinn Stefansson; Carola Tengström; Unnur Thorsteinsdóttir; Francisco J Tinahones; Renaud Touraine; Louis Vallée; Ellen van Binsbergen; Nathalie Van der Aa; Catherine Vincent-Delorme; Sophie Visvikis-Siest; Peter Vollenweider; Henry Völzke; Anneke T Vulto-van Silfhout; Gérard Waeber; Carina Wallgren-Pettersson; Robert M Witwicki; Simon Zwolinksi; Joris Andrieux; Xavier Estivill; James F Gusella; Omar Gustafsson; Andres Metspalu; Stephen W Scherer; Kari Stefansson; Alexandra I F Blakemore; Jacques S Beckmann; Philippe Froguel
Journal:  Nature       Date:  2011-08-31       Impact factor: 49.962

9.  The 16p11.2 locus modulates brain structures common to autism, schizophrenia and obesity.

Authors:  A M Maillard; A Ruef; F Pizzagalli; E Migliavacca; L Hippolyte; S Adaszewski; J Dukart; C Ferrari; P Conus; K Männik; M Zazhytska; V Siffredi; P Maeder; Z Kutalik; F Kherif; N Hadjikhani; J S Beckmann; A Reymond; B Draganski; S Jacquemont
Journal:  Mol Psychiatry       Date:  2014-11-25       Impact factor: 15.992

10.  Microduplications of 16p11.2 are associated with schizophrenia.

Authors:  Shane E McCarthy; Vladimir Makarov; George Kirov; Anjene M Addington; Jon McClellan; Seungtai Yoon; Diana O Perkins; Diane E Dickel; Mary Kusenda; Olga Krastoshevsky; Verena Krause; Ravinesh A Kumar; Detelina Grozeva; Dheeraj Malhotra; Tom Walsh; Elaine H Zackai; Paige Kaplan; Jaya Ganesh; Ian D Krantz; Nancy B Spinner; Patricia Roccanova; Abhishek Bhandari; Kevin Pavon; B Lakshmi; Anthony Leotta; Jude Kendall; Yoon-Ha Lee; Vladimir Vacic; Sydney Gary; Lilia M Iakoucheva; Timothy J Crow; Susan L Christian; Jeffrey A Lieberman; T Scott Stroup; Terho Lehtimäki; Kaija Puura; Chad Haldeman-Englert; Justin Pearl; Meredith Goodell; Virginia L Willour; Pamela Derosse; Jo Steele; Layla Kassem; Jessica Wolff; Nisha Chitkara; Francis J McMahon; Anil K Malhotra; James B Potash; Thomas G Schulze; Markus M Nöthen; Sven Cichon; Marcella Rietschel; Ellen Leibenluft; Vlad Kustanovich; Clara M Lajonchere; James S Sutcliffe; David Skuse; Michael Gill; Louise Gallagher; Nancy R Mendell; Nick Craddock; Michael J Owen; Michael C O'Donovan; Tamim H Shaikh; Ezra Susser; Lynn E Delisi; Patrick F Sullivan; Curtis K Deutsch; Judith Rapoport; Deborah L Levy; Mary-Claire King; Jonathan Sebat
Journal:  Nat Genet       Date:  2009-10-25       Impact factor: 38.330

View more
  72 in total

1.  Distal chromosome 16p11.2 duplications containing SH2B1 in patients with scoliosis.

Authors:  Brooke Sadler; Gabe Haller; Lilian Antunes; Xavier Bledsoe; Jose Morcuende; Philip Giampietro; Cathleen Raggio; Nancy Miller; Yared Kidane; Carol A Wise; Ina Amarillo; Nephi Walton; Mark Seeley; Darren Johnson; Conner Jenkins; Troy Jenkins; Matthew Oetjens; R Spencer Tong; Todd E Druley; Matthew B Dobbs; Christina A Gurnett
Journal:  J Med Genet       Date:  2019-02-25       Impact factor: 6.318

2.  Chemogenetic Activation of Prefrontal Cortex Rescues Synaptic and Behavioral Deficits in a Mouse Model of 16p11.2 Deletion Syndrome.

Authors:  Wei Wang; Benjamin Rein; Freddy Zhang; Tao Tan; Ping Zhong; Luye Qin; Zhen Yan
Journal:  J Neurosci       Date:  2018-05-31       Impact factor: 6.167

3.  Identifying CNVs in 15q11q13 and 16p11.2 of Patients with Seizures Increases the Rates of Detecting Pathogenic Changes.

Authors:  Gabrielle S Vianna; Mariana L Freitas; Valdirene T de Oliveira; Rafaella X Pietra; Michele da S Gonçalves; Patrícia P O Rocha; Rejane A C Monteiro; Luana C A Ferreira; Rosana R Xavier; Andréia M Carvalho; Patrícia R de M Lima; Maria Augusta N P Monteiro; Elvis C Mateo; Juliana G Giannetti; Giovana da C César; Joziele de S Lima; Paula F V Medeiros; Fernanda S Jehee
Journal:  Mol Syndromol       Date:  2016-11-01

4.  Genomic Disorders and Neurocognitive Impairment in Pediatric CKD.

Authors:  Miguel Verbitsky; Amy J Kogon; Matthew Matheson; Stephen R Hooper; Craig S Wong; Bradley A Warady; Susan L Furth; Ali G Gharavi
Journal:  J Am Soc Nephrol       Date:  2017-03-27       Impact factor: 10.121

5.  Exons as units of phenotypic impact for truncating mutations in autism.

Authors:  Andrew H Chiang; Jonathan Chang; Jiayao Wang; Dennis Vitkup
Journal:  Mol Psychiatry       Date:  2020-10-27       Impact factor: 15.992

6.  Schizophrenia and the neurodevelopmental continuum:evidence from genomics.

Authors:  Michael J Owen; Michael C O'Donovan
Journal:  World Psychiatry       Date:  2017-10       Impact factor: 49.548

7.  16p11.2 transcription factor MAZ is a dosage-sensitive regulator of genitourinary development.

Authors:  Meade Haller; Jason Au; Marisol O'Neill; Dolores J Lamb
Journal:  Proc Natl Acad Sci U S A       Date:  2018-02-05       Impact factor: 11.205

Review 8.  Genomic Disorders in Psychiatry-What Does the Clinician Need to Know?

Authors:  Chelsea Lowther; Gregory Costain; Danielle A Baribeau; Anne S Bassett
Journal:  Curr Psychiatry Rep       Date:  2017-09-20       Impact factor: 5.285

9.  Comprehensive genomic analysis of patients with disorders of cerebral cortical development.

Authors:  Wojciech Wiszniewski; Pawel Gawlinski; Tomasz Gambin; Monika Bekiesinska-Figatowska; Ewa Obersztyn; Dorota Antczak-Marach; Zeynep Hande Coban Akdemir; Tamar Harel; Ender Karaca; Marta Jurek; Katarzyna Sobecka; Beata Nowakowska; Malgorzata Kruk; Iwona Terczynska; Alicja Goszczanska-Ciuchta; Mariola Rudzka-Dybala; Ewa Jamroz; Antoni Pyrkosz; Anna Jakubiuk-Tomaszuk; Piotr Iwanowski; Dorota Gieruszczak-Bialek; Malgorzata Piotrowicz; Maria Sasiadek; Iwona Kochanowska; Barbara Gurda; Barbara Steinborn; Mateusz Dawidziuk; Jennifer Castaneda; Pawel Wlasienko; Natalia Bezniakow; Shalini N Jhangiani; Dorota Hoffman-Zacharska; Jerzy Bal; Elzbieta Szczepanik; Eric Boerwinkle; Richard A Gibbs; James R Lupski
Journal:  Eur J Hum Genet       Date:  2018-04-30       Impact factor: 4.246

Review 10.  Getting to the Cores of Autism.

Authors:  Lilia M Iakoucheva; Alysson R Muotri; Jonathan Sebat
Journal:  Cell       Date:  2019-09-05       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.